Nitropress

Active Ingredient(s): Nitroprusside
FDA Approved: * September 8, 1981
Pharm Company: * ABBOTT
Category: Heart (Cardiac)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Nitropress Overview

Sodium nitroprusside (SNP), sold under the brand name Nitropress among others, is a medication use to lower blood pressure. This may be done if the blood pressure is really high and resulting in symptoms, in certain types of heart failure, and during surgery to decrease bleeding. It is used by continuous injection into a vein. Onset is typically immediate and effects last for up to ten minutes.[1] Common side effects include low blood pressure and cyanide toxicity. Other serious side effects ...

Read more Nitropress Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Sodium_nitroprusside

Recent Nitropress Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Nitroprusside
  • Injection: 25mg/ml, 50mg, 50mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Nitropress: (3 results)

Sorted by National Drug Code
  • 0187-4302 Nitropress 50 mg/2ml Intravenous Injection, Solution, Concentrate by Valeant Pharmaceuticals North America LLC
  • 0409-3024 Nitropress 50 mg/2ml Intravenous Injection, Solution, Concentrate by Hospira, Inc.
  • 42998-302 Nitropress 50 mg/2ml Intravenous Injection, Solution, Concentrate by Marathon Pharmaceuticals, LLC

Other drugs which contain Nitroprusside or a similar ingredient: (1 result)